Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell ‘don't eat me’ signals off and ‘eat me’ signals on

The long‐term survival of osteosarcoma patients with metastatic or recurrent disease remains dismal, and new therapeutic options are urgently needed. The purpose of our study was to compare the efficacy of CD47 mAb plus doxorubicin combination therapy in mouse models of osteosarcoma with CD47 mAb an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanty, Suchismita, Aghighi, Maryam, Yerneni, Ketan, Theruvath, Johanna Lena, Daldrup‐Link, Heike E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763764/
https://www.ncbi.nlm.nih.gov/pubmed/31376208
http://dx.doi.org/10.1002/1878-0261.12556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763764/
https://www.ncbi.nlm.nih.gov/pubmed/31376208
http://dx.doi.org/10.1002/1878-0261.12556

Ejemplares similares